Mid-Winter Conference on Psychopharmacology (March 5-6, 2016)

Mid-Winter Conference on Psychopharmacology (March 5-6, 2016)

Third Annual Psychopharmacology Mid-winter Conference March 5th and 6th

Provided by:

APA: Division 55

CPA: Division V

March 5-6, 2016

Alliant International University
10455 Pomerado Rd
San Diego, CA 92131

Sponsored by
California Psychological Association (CPA), CPA’s Division of Clinical Psychopharmacology (Division V), and the Society for the Advancement of Pharmacotherapy (APA Division 55)

Hear about the latest information related to issues of serious mental illness, the pharmacotherapeutic options for treatment
of these conditions (including psychotherapeutics), and future trends in treatment. Click here for more information. 


James H. Bray, Ph.D. is an Associate Professor of Family and Community Medicine.  He was the 2015 President of the Texas Psychological Association and the 2009 President of the American Psychological Association. He is a past president of Division 55. Dr. Bray’s NIH funded research focuses on adolescent substance use, divorce, remarriage and stepfamilies.  He has published over 200 articles in major journal and books. He is the director of a federal Health Resources Service Administration faculty development program for physicians and was the director of the Substance Abuse and Mental Health Services Administration funded project on screening, brief intervention and referral to treatment (SBIRT) project for primary care residents.  He is a pioneer in collaborative healthcare and primary care psychology. He also maintains an active clinical practice focusing on health psychology children and families.

Joseph E. Comaty received his M.S. in experimental psychology from Villanova University; his Ph.D. in psychology with a specialization in clinical neuropsychology from the Rosalind Franklin University of Medicine and Science, in Illinois; and his postdoctoral Masters Degree in clinical psychopharmacology from Alliant University/CSPP of California. He is a licensed psychologist under the Louisiana State Board of Examiners of Psychologists (LSBEP) and a licensed Medical Psychologist (i.e., prescribing psychologist) under the Louisiana State Board of Medical Examiners. He retired from the Louisiana Department of Health and Hospitals, Office of Behavioral Health in 2013 where he was the Chief Psychologist and Medical Psychologist and Director of the Division of Quality Management. He is an adjunct assistant professor in psychology at Louisiana State University (LSU) in Baton Rouge and serves as emeritus faculty of the Southern Louisiana Internship Consortium (SLIC) in psychology at LSU. He served as member of the LSBEP from 2006 to 2010 and as its chair from 2010 to 2011; he is a past charter member and chair of the RxP Designation Committee of APA, and is a current site reviewer for APA’s Committee on Accreditation. He is a member of the Model Act and Regulation Revision Committee for the Association of State and Provincial Psychology Boards (ASPPB). His research is in the areas of behavior therapy, pharmacology, and clinical psychopharmacology. He is the author of over 60 articles, book chapters, and presentations. He is a co-author of the psychopharmacology textbook, Julien’s Primer of Drug Action, the most recent edition being published in April 2014. He has served on federal grant review committees and has been a reviewer for Psychiatric Services; The Journal of Gerontology: Psychological Sciences; the Journal of Behavioral Health Services and Research; and the Journal of Psychology & Clinical Psychiatry.

Alex Kopelowicz, M.D. is Professor and Vice-Chair in the Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Medical Director of the  San Fernando Mental Health Center (SFMHC), a community mental health center operated by the Department of Mental  Health of Los Angeles County and Chief of Psychiatry at Olive View-UCLA Medical Center.  Dr. Kopelowicz has been a frequent lecturer on biobehavioral treatment and psychiatric rehabilitation techniques.  He has written over 100 articles and book chapters on these subjects.  Dr. Kopelowicz has been the recipient of several grants from the National Institute of Mental Health and the National Alliance for Research on Schizophrenia and Depression. His work has focused on culturally adapting evidence-based psychosocial treatment approaches for Hispanic-Americans with serious mental disorders to improve illness self-management, treatment adherence and functional outcomes.  Dr. Kopelowicz was born in Buenos Aires, Argentina and immigrated with his family to New York City at
a young age.  He remains fluent in Spanish, which has been enormously helpful in his work. He graduated from Haverford College with a B.A. in Psychology, and went on to receive his medical education at Rutgers Medical School in New Jersey.  He completed his psychiatric residency at the UCLA/San Fernando Valley program.  He is married and he and his wife have three children.

Veronica Perez, Ph.D. is an Assistant Professor in the San Diego, Clinical PhD Program of the California School of Professional Psychology at Alliant International University.  She received her PhD in 2008 from the University of Oregon.  Her research interests include: Neural correlates of psychosis and schizophrenia, biomarkers of severe psychopathology, pathophysiology of cognition, EEG abnormalities in patients at clinical high-risk for psychosis, and neurophysiological response to cognitive interventions. She is a faculty member in the newly developed Neuroscience Institute through the Alliant Research Foundation on the San Diego Campus of Alliant International University.

Beth N. Rom-Rymer, Ph.D., a graduate of the first class of women at Princeton University in 1973, is in independent clinical practice in Chicago. She also has a national consulting forensics practice, specializing in sexual violence, sexual harassment, and other forms of trauma. Trained in Clinical Psychopharmacology in the late 1990’s, Dr. Rom-Rymer became one of the first presidents of Division 55 in 2004 and one of the national leaders of the RxP movement.  As a two-term president of the Illinois Psychological Association (2011-2012, 2013-2014), Dr. Rom-Rymer created a groundswell of support for RxP in Illinois and led her Association to victory in the passage of the Illinois RxP law in May 2014. Illinois thus became the third state in the nation to pass an RxP law. Dr. Rom-Rymer continues to crisscross her state as the IPA is implementing the law:  building alliances with organized medicine, organized psychiatry, law enforcement, state and private educational institutions, and some of the largest social service and mental health consumer organizations in the state.  Other states’ movements have been re-invigorated and Dr. Rom-Rymer has been working with state leaders to build the necessary infrastructure to pass RxP legislation in their states.  Dr. Rom-Rymer was a co-author of “Practice Guidelines Regarding Psychologists Involved in Pharmacological Issues” (American Psychologist December 2011). She has won numerous state and national awards for outstanding leadership and advocacy, including the 2012 and 2014 Distinguished Psychologist Award from the Illinois Psychological Association; the 2007 National Outstanding Leadership Award from Division 55; the 2014 Outstanding Contribution to the Advancement of Pharmacotherapy at the National Level from Division 55; an APA Presidential Citation in February 2015; and the APA Karl F. Heiser Award for Advocacy in August 2015.

Irwin Rosenfarb, Ph.D. is a Professor of Clinical Psychology and Program Director of the Clinical Ph.D. program of the California School of Professional Psychology San Diego Campus at Alliant International University. He received his PhD in 1986 from the University of North Carolina, Greensboro.  Dr. Rosenfarb has been involved in programmatic research involving the treatment of methods of treatment for persons with severe mental health problems, particular involving psychosis and mood disorders.  Much of his work has focused on environmental, cultural and behavioral health factors that are related to treatment outcome for persons with schizophrenia.

Morgan T. Sammons is Executive Officer of the National Register of Health Service Psychologists. He is a retired Captain in the US Navy.  He is a prescribing psychologist and one of the first graduates of the Department of Defense’s Psychopharmacology Demonstration Project. Dr. Sammons is a Fellow of the American Psychological Association, past- president of APA’s division 55, and past Chair of the California Psychological Association’s Division 5 (Psychopharmacology) and a past president of the Maryland Psychological Association.  He is a diplomate of the American Board of Professional Psychology (Clinical).

Nadia Webb, Psy,D., MS. Is a clinical psychologist in New Mexico.  She is on the New Mexico Board of

  Psychologist Examiners and a Medical Psychologist with Advanced Practice in Louisiana.  She is a Diplomate of the American Board of Professional Neuropsychology and Diplomate of the American Board of Pediatric Neuropsychology. She provides neuropsychological services for children and adults, specializing in assessment and treatment of PTSD and neurobehavioral impairments. She is an Independent Medical Examiner for the Social Security Administration, Department of Social Services, Harrisonburg Police Department, Rockingham County School Board, Loudoun County School Board, Department of Rehabilitative Services, and juvenile and adult courts.

To purchase tickets for Fundraising Dinner without registering click here!

Sponsorship Opportunities Available
Click here to download the Sponsor Form.
When complete email to: dchase@cpapsych.org or
Snail mail to: CPA – Attention: D. Chase 1231 I Street, Suite 204 Sacramento, CA 95814

 There will also have ample time for networking!